About
Denitsa Milanova, PhD, is a biotech founder and executive focused on oncology, genetics, and longevity-related therapeutics. Insilico Medicine states she founded and has served as CEO of Medici Therapeutics since October 2022, after research roles at the Wyss Institute and Harvard Medical School with George Church. She also serves as an independent non-executive director of Insilico Medicine and has been publicly associated with longevity and gene-therapy discussions through Marble Therapeutics.
Areas of interest
biotechimmuno-oncologygeneticsgene therapylongevityaging biologyskin biologysingle-cell omicsbiotech entrepreneurship